These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23710678)

  • 1. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
    Goncalves D; Rebelo V; Barbosa P; Gomes A
    Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
    Kern KU; Quandel T; Theis S; Schubert T
    Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report.
    Sayanlar J; Guleyupoglu N; Portenoy R; Ashina S
    J Headache Pain; 2012 Oct; 13(7):587-9. PubMed ID: 22717586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
    Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
    Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C; Heskamp ML
    Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
    Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
    Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
    Burness CB; McCormack PL
    Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
    Treede RD; Wagner T; Kern KU; Husstedt IW; Arendt G; Birklein F; Cegla T; Freynhagen R; Gockel HH; Heskamp ML; Jager H; Joppich R; Maier C; Leffler A; Nagelein HH; Rolke R; Seddigh S; Sommer C; Stander S; Wasner G; Baron R
    Curr Med Res Opin; 2013 May; 29(5):527-38. PubMed ID: 23444968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Blair HA
    Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
    Backonja MM; Malan TP; Vanhove GF; Tobias JK;
    Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
    Hansson P; Jensen TS; Kvarstein G; Strömberg M
    Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain.
    Raber JM; Reichelt D; Grüneberg-Oelker U; Philipp K; Stubbe-Dräger B; Husstedt IW
    Acta Neurol Belg; 2015 Sep; 115(3):335-43. PubMed ID: 25421590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.